The Heart-Lung Bridge
Exploring the intricate medical technology that temporarily supports vital organ function during complex cardiac surgeries.
What is CPB? 👇 Explore Components ⚙️Dive in with Flashcard Learning!
🎮 Play the Wiki2Web Clarity Challenge Game🎮
What is CPB?
Temporary Life Support
Cardiopulmonary bypass (CPB), often referred to as the heart-lung machine or "the pump," is a sophisticated medical technique that temporarily assumes the functions of the heart and lungs during open-heart surgery. This extracorporeal device ensures the continuous circulation and oxygenation of blood throughout the patient's body, creating a still, bloodless surgical field for the surgeon to operate on the heart with precision.
The Role of the Perfusionist
The operation of the cardiopulmonary bypass machine is managed by a highly specialized healthcare professional known as a perfusionist. This individual is responsible for mechanically circulating and oxygenating the patient's blood, meticulously monitoring vital parameters to ensure the patient's physiological stability while the heart and lungs are bypassed.
Enabling Complex Procedures
CPB is indispensable for a wide range of intricate cardiac operations. By taking over the circulatory and respiratory functions, it allows surgeons to perform delicate procedures on the heart, such as coronary artery bypass grafting (CABG) or valve repairs, which would be exceedingly difficult or impossible on a beating heart. It also prevents air from entering the systemic circulation, enhancing surgical safety and visibility.
Clinical Uses
Primary Surgical Applications
Cardiopulmonary bypass is a cornerstone in various cardiac surgical procedures, enabling surgeons to work on a still heart. Key applications include:
- Coronary Artery Bypass Surgery (CABG): Rerouting blood flow around blocked arteries.
- Cardiac Valve Repair/Replacement: Addressing issues with aortic, mitral, tricuspid, or pulmonic valves.
- Septal Defect Repair: Correcting large defects in the heart's septa, such as atrial or ventricular septal defects.
- Congenital Heart Defect Palliation/Repair: Managing complex birth defects like Tetralogy of Fallot or transposition of the great vessels.
- Organ Transplantation: Essential for heart, lung, heart-lung, and even liver transplantations.
- Aneurysm Repair: Addressing large aortic or cerebral aneurysms.
- Pulmonary Thromboendarterectomy/Thrombectomy: Removing chronic or acute blood clots from the pulmonary arteries.
- Isolated Limb Perfusion: A specialized technique for delivering high-dose chemotherapy to a limb.
Therapeutic Hypothermia
CPB can be precisely controlled to induce total body hypothermia, a state where the body's metabolic rate is significantly slowed. This allows for periods of up to 45 minutes without blood flow (perfusion) to organs, minimizing the risk of damage, particularly to the brain, which would otherwise occur within minutes at normal body temperature. This technique is invaluable in certain complex surgical scenarios where temporary circulatory arrest is necessary.
Temperature Management
During CPB, the patient's blood is often cooled and then returned to the body. This cooled blood reduces the body's basal metabolic rate, thereby decreasing its oxygen demand. While cooled blood typically has higher viscosity, it is diluted with crystalloid or colloidal solutions to maintain optimal flow. Body temperature is usually maintained between 28 to 32°C (82 to 90°F), and careful monitoring ensures appropriate blood pressure for all organs. CPB can also be used to safely rewarm patients suffering from severe hypothermia, provided their core temperature is above 16°C.
ECMO: A Simplified Bypass
Extracorporeal Membrane Oxygenation (ECMO) represents a streamlined version of the heart-lung machine. It incorporates a centrifugal pump and an oxygenator to temporarily support the function of the heart and/or lungs. ECMO is particularly useful for patients recovering from cardiac surgery with heart or lung dysfunction, those with acute pulmonary failure, massive pulmonary embolisms, or lung trauma from infections. It provides a crucial period for the heart and lungs to heal and recover, though it is considered a temporary intervention. Patients with terminal conditions, cancer, severe nervous system damage, or uncontrolled sepsis are generally not candidates for ECMO.
Risks & Complications
Balancing Benefits and Hazards
While CPB is a life-saving technology, it is not without inherent risks and potential complications. Its use is typically limited to the several hours required for cardiac surgery due to its impact on the body's physiological systems. CPB is known to activate the coagulation cascade and stimulate inflammatory responses, which can lead to hemolysis (red blood cell destruction) and coagulopathies (blood clotting disorders). These issues can worsen as complement proteins accumulate on the membrane oxygenators.
Manufacturer recommendations typically limit oxygenator use to a maximum of six hours, though extended use up to ten hours may occur with careful monitoring. For longer support, specialized membrane oxygenators can operate for up to 31 days.
Common Complications
The most frequently encountered complication associated with CPB is a protamine reaction during the reversal of anticoagulation. Protamine reactions can manifest in three types, each potentially life-threatening:
- Type I: Severe hypotension (low blood pressure).
- Type II: Anaphylaxis (a severe allergic reaction).
- Type III: Pulmonary hypertension (high blood pressure in the lung arteries).
Patients with prior exposure to protamine, such as those with a history of vasectomy (protamine is found in sperm) or diabetics using NPH insulin (which contains protamine), face an elevated risk of Type II reactions due to cross-sensitivity. Management involves immediately stopping protamine infusion, administering corticosteroids for all types, chlorphenamine for Type II, and potentially re-dosing heparin or returning to bypass for Type III reactions.
Neurological Considerations
CPB may contribute to immediate cognitive decline, often referred to as "pumphead." The heart-lung circulation system and the surgical connections can release various debris into the bloodstream, including fragments of blood cells, tubing material, and arterial plaque. For instance, clamping and connecting the aorta to the bypass tubing can dislodge emboli, potentially blocking blood flow and causing mini-strokes. Other factors contributing to neurological impact include episodes of hypoxia (low oxygen), fluctuations in body temperature, abnormal blood pressure, irregular heart rhythms, and post-operative fever. While these risks are recognized, ongoing research aims to better understand and mitigate their impact on cerebral perfusion and cognitive function.
Core Components
Functional Units
Cardiopulmonary bypass devices are comprised of two primary functional units: the pump and the oxygenator. These units work in concert to remove deoxygenated blood from the patient's body and return oxygen-rich blood through a network of specialized tubes. Additionally, a heat exchanger is integrated into the circuit to precisely regulate the patient's body temperature by warming or cooling the circulating blood. To prevent clotting within the circuit, all internal components are coated with heparin or another anticoagulant.
Tubing and Cannulae
The various components of the CPB circuit are interconnected by a series of flexible tubes, typically constructed from silicone rubber or PVC. These tubes facilitate the flow of blood between the patient and the machine. Crucially, multiple cannulae (thin tubes) are surgically inserted into the patient's body at specific locations, depending on the type of surgery. A venous cannula withdraws oxygen-depleted blood, while an arterial cannula infuses oxygen-rich blood back into the arterial system. Cannula size selection is determined by patient size, weight, anticipated blood flow rate, and the dimensions of the vessel being cannulated. A dedicated cardioplegia cannula delivers a solution to temporarily stop the heart.
Pumps: Centrifugal vs. Roller
Two primary types of pumps are utilized in CPB circuits:
- Centrifugal Pump: Increasingly common, this pump generates blood flow by altering the speed of a rotating head, using centrifugal force. It is considered superior to roller pumps as it helps prevent over-pressurization, line clamping, or kinking, and generally causes less damage to blood components (e.g., hemolysis).
- Roller Pump (Peristaltic Pump): This traditional pump uses rotating rollers to "massage" the tubing, gently propelling blood. While more affordable, roller pumps are susceptible to over-pressurization if lines become obstructed and carry a higher risk of massive air embolism, thus requiring constant, vigilant supervision by the perfusionist.
Oxygenator and Heat Exchangers
The oxygenator is a critical component designed to infuse oxygen into the patient's blood and remove carbon dioxide, effectively mimicking the function of the lungs. Historically, direct-contact oxygenators were used, but modern systems primarily employ membrane oxygenators, which introduce a gas-permeable membrane between blood and oxygen to minimize blood trauma. Heat exchangers are integral for temperature control, warming or cooling the blood within the circuit as needed to induce or reverse hypothermia. A separate heat exchanger is also required for the cardioplegia line, ensuring the solution is delivered at the appropriate temperature for myocardial protection.
Procedural Technique
Pre-operative Planning
Successful cardiopulmonary bypass necessitates meticulous pre-operative planning, involving close coordination among the surgical team: the surgeon, anesthesiologist, perfusionist, and nursing staff. Key aspects of this planning include determining the optimal cannulation sites, establishing cooling strategies (if hypothermia is intended), and defining cardio-protective measures to safeguard the heart during the bypass period.
Cannulation Strategy
The specific cannulation strategy is tailored to the individual patient and the nature of the surgical procedure. Typically, a cannula is placed in the right atrium, vena cava, or femoral vein to drain deoxygenated blood from the body into the CPB circuit. The oxygenated blood is then returned to the patient, usually via a cannula inserted into the ascending aorta. Alternative arterial cannulation sites, such as the femoral, axillary, or brachiocephalic arteries, may be chosen based on surgical requirements. Once cannulated, venous blood flows by gravity into a reservoir, where it is filtered, temperature-regulated, and oxygenated before being mechanically pumped back into the patient's arterial system.
Intra-operative Procedure
A CPB circuit must be meticulously primed with fluid and all air expunged from the arterial line/cannula before connection to the patient. The circuit is primed with a crystalloid solution, and sometimes blood products are also added. Prior to cannulation (typically after opening the pericardium when using central cannulation), heparin or another anticoagulant is administered until the activated clotting time is above 480 seconds. The arterial cannulation site is inspected for calcification or other disease, often using preoperative imaging or an ultrasound probe to help identify aortic calcifications that could potentially become dislodged and cause an occlusion or stroke. Once the cannulation site has been deemed safe, two concentric, diamond-shaped pursestring sutures are placed in the distal ascending aorta. A stab incision with a scalpel is made within the pursestrings, and the arterial cannula is passed through the incision. It is important the cannula is passed perpendicular to the aorta to avoid creating an aortic dissection. The pursestrings sutures are cinched around the cannula using a tourniquet and secured to the cannula. At this point, the perfusionist advances the arterial line of the CPB circuit, and the surgeon connects the arterial line coming from the patient to the arterial line coming from the CPB machine. Care must be taken to ensure no air is in the circuit when the two are connected, or else the patient could develop an air embolism. Other sites for arterial cannulation include the axillary artery, brachiocephalic artery, or femoral artery. Aside from the differences in location, venous cannulation is performed similarly to arterial cannulation. Since calcification of the venous system is less common, the inspection or use of an ultrasound for calcification at the cannulation sites is unnecessary. Also, because the venous system is under much less pressure than the arterial system, only a single suture is required to hold the cannula in place. If only a single cannula is to be used (dual-stage cannulation), it is passed through the right atrial appendage, through the tricuspid valve, and into the inferior vena cava. If two cannulas are required (single-stage cannulation), the first one is typically passed through the superior vena cava and the second through the inferior vena cava. The femoral vein may also be cannulated in select patients. If the heart must be stopped for the operation, cardioplegia cannulas are also required. Antegrade cardioplegia (forward flowing, through the heart's arteries), retrograde cardioplegia (backwards flowing, through the heart's veins), or both types may be used depending on the operation and surgeon preference. For antegrade cardioplegia, a small incision is made in the aorta proximal to the arterial cannulation site (between the heart and arterial cannulation site), and the cannula is placed through this to deliver cardioplegia to the coronary arteries. For retrograde cardioplegia, an incision is made on the posterior (back) surface of the heart through the right ventricle. The cannula is placed in this incision, passed through the tricuspid valve, and into the coronary sinus. The cardioplegia lines are connected to the CPB machine. At this point, the patient is ready to go on bypass. Blood from the venous cannula(s) enters the CPB machine by gravity where it is oxygenated and cooled (if necessary) before returning to the body through the arterial cannula. Cardioplegia can now be administered to stop the heart, and a cross-clamp is placed across the aorta between the arterial cannula and cardioplegia cannula to prevent the arterial blood from flowing backwards into the heart. Setting appropriate blood pressure targets to maintain the health and function of the organs including the brain and kidney are important considerations. Once the patient is ready to come off of bypass support, the cross-clamp and cannulas are removed, and protamine sulfate is administered to reverse the anticoagulative effects of heparin.
Cardioplegia: Heart Protection
Cardioplegia is a specialized fluid solution administered to protect the heart during CPB by inducing cardiac arrest. This intentional cessation of heart activity significantly reduces the heart's metabolic demand, preserving myocardial integrity during the surgical period. Cardioplegia can be delivered antegrade (forward-flowing, through the coronary arteries, typically via the aortic root) or retrograde (backward-flowing, through the cardiac veins via the coronary sinus), or both. While various cardioplegia solutions exist, most function by inhibiting fast sodium currents in heart cells, preventing the conduction of action potentials, or by modulating calcium's effects on myocytes.
Historical Milestones
Early Concepts and Pioneers
The concept of temporarily bypassing the heart and lungs has roots dating back to the 17th century with Robert Hooke's ideas on oxygenators. However, practical heart-lung machines were not feasible until the discovery of heparin in 1916, which prevented blood coagulation. In 1885, Austrian-German physiologist Maximilian von Frey constructed an early prototype. Soviet scientist Sergei Brukhonenko further developed a heart-lung machine for total body perfusion, the "Autojektor," in 1926, used in animal experiments.
First Human Applications
Significant breakthroughs occurred in the mid-20th century. On April 5, 1951, a team led by Dr. Clarence Dennis at the University of Minnesota Medical Center performed the first human operation involving open cardiotomy with temporary mechanical support of both heart and lung functions. Although the patient did not survive due to a complex congenital heart defect, the machine's viability was demonstrated. The first successful mechanical support of left ventricular function was achieved on July 3, 1952, by Forest Dewey Dodrill using the Dodrill-GMR machine. The first truly successful open-heart procedure on a human utilizing a heart-lung machine was performed by John Gibbon and Frank F. Allbritten Jr. on May 6, 1953, at Thomas Jefferson University Hospital.
Evolution and Refinement
Gibbon's machine was subsequently refined into a reliable instrument by a surgical team led by John W. Kirklin at the Mayo Clinic in the mid-1950s, paving the way for wider adoption. The development of oxygenators also progressed significantly; early "direct contact" bubble oxygenators were eventually replaced by more advanced "membrane oxygenators" in the 1960s, which introduced a gas-permeable membrane to reduce blood trauma. Further innovations, such as Ken Litzie's 1983 patent for a closed emergency heart bypass system, aimed to simplify and rapidly deploy CPB in non-surgical settings, improving patient survival after cardiac arrest.
Teacher's Corner
Edit and Print this course in the Wiki2Web Teacher Studio

Click here to open the "Cardiopulmonary Bypass" Wiki2Web Studio curriculum kit
Use the free Wiki2web Studio to generate printable flashcards, worksheets, exams, and export your materials as a web page or an interactive game.
True or False?
Test Your Knowledge!
Gamer's Corner
Are you ready for the Wiki2Web Clarity Challenge?

Unlock the mystery image and prove your knowledge by earning trophies. This simple game is addictively fun and is a great way to learn!
Play now
References
References
- Man survives 16 days without a heart United Press International. April 3, 2008.
Feedback & Support
To report an issue with this page, or to find out ways to support the mission, please click here.
Disclaimer
Important Notice
This page was generated by an Artificial Intelligence and is intended for informational and educational purposes only. The content is based on a snapshot of publicly available data from Wikipedia and may not be entirely accurate, complete, or up-to-date.
This is not medical advice. The information provided on this website is not a substitute for professional medical consultation, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or surgical procedure. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
The creators of this page are not responsible for any errors or omissions, or for any actions taken based on the information provided herein.